Lead Regulations, 2001 › 8 Medical surveillance
Lead Regulations 8(2)(d)
| ID | 3232 |
|---|---|
| Citation | Lead Regulations 8(2)(d) |
| Instrument | Lead Regulations, 2001 |
| Instrument type | Regulation |
| Part | — |
| Number | 8 |
| Heading | Medical surveillance |
| Subsection | (2) |
| Paragraph | (d) |
| Subparagraph | — |
| Item | — |
| Text role | proviso |
| Sort key | 18.0008.00190 |
| Source | GNR.236 of 28 February 2002 |
| Amended by | — |
| In force from | 2002-02-28 |
| Status | In force |
| Verified | No |
| Note | — |
| Text | Provided further that the removal blood lead level of 60 µg/100 mℓ may be phased-in by reducing the level from 80 µg/100 mℓ to 75 µg/100 mℓ with effect from 30 June 2002, and then by a further 5 µg/100 mℓ every twelve months thereafter in order to reach 60 µg/100 mℓ by 30 June 2005, as depicted in the Table contained in Annexure C to these Regulations; |
Sign in to edit this row or mark it verified.